Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
NZ245759A - Substituted hexahydroazepinones and tetrahydrobenzazepinones, preparation, intermediates and pharmaceutical compositions thereof - Google Patents
[go: Go Back, main page]

NZ245759A - Substituted hexahydroazepinones and tetrahydrobenzazepinones, preparation, intermediates and pharmaceutical compositions thereof - Google Patents

Substituted hexahydroazepinones and tetrahydrobenzazepinones, preparation, intermediates and pharmaceutical compositions thereof

Info

Publication number
NZ245759A
NZ245759A NZ245759A NZ24575993A NZ245759A NZ 245759 A NZ245759 A NZ 245759A NZ 245759 A NZ245759 A NZ 245759A NZ 24575993 A NZ24575993 A NZ 24575993A NZ 245759 A NZ245759 A NZ 245759A
Authority
NZ
New Zealand
Prior art keywords
oxo
nmr
phenyl
tert
cdci
Prior art date
Application number
NZ245759A
Other languages
English (en)
Inventor
John A Lowe
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NZ245759A publication Critical patent/NZ245759A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ245759A 1992-01-27 1993-01-26 Substituted hexahydroazepinones and tetrahydrobenzazepinones, preparation, intermediates and pharmaceutical compositions thereof NZ245759A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82567792A 1992-01-27 1992-01-27

Publications (1)

Publication Number Publication Date
NZ245759A true NZ245759A (en) 1997-06-24

Family

ID=25244657

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ245759A NZ245759A (en) 1992-01-27 1993-01-26 Substituted hexahydroazepinones and tetrahydrobenzazepinones, preparation, intermediates and pharmaceutical compositions thereof

Country Status (19)

Country Link
EP (1) EP0625145A1 (sr)
JP (1) JPH07503465A (sr)
KR (1) KR950700257A (sr)
CN (1) CN1074903A (sr)
AU (1) AU3276193A (sr)
BR (1) BR9207071A (sr)
CA (1) CA2117367A1 (sr)
CZ (1) CZ391092A3 (sr)
FI (1) FI943513A0 (sr)
HU (1) HUT70496A (sr)
IL (1) IL104472A0 (sr)
MX (1) MX9300409A (sr)
NO (1) NO942775L (sr)
NZ (1) NZ245759A (sr)
RU (1) RU94038063A (sr)
TW (1) TW213901B (sr)
WO (1) WO1993015059A1 (sr)
YU (1) YU4393A (sr)
ZA (1) ZA93582B (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097688A1 (es) * 1993-07-14 1997-04-01 Pfizer Hexahidroazepinonas y tetrahidrobenzazepinonas sustituidas.
JP2862675B2 (ja) * 1993-07-26 1999-03-03 フアイザー・インコーポレイテツド 選択的コレシストキニン−b受容体拮抗薬としてのテトラヒドロ−1h−ベンゾアゼピノンおよびヘキサヒドロアゼピノン
CA2176019A1 (en) * 1993-11-22 1995-06-01 John J. Baldwin 3-acylaminobenzazepines
US5453424A (en) * 1993-11-22 1995-09-26 Merck & Co., Inc. Furanodiazepines
WO1996010564A1 (en) * 1994-10-04 1996-04-11 Pfizer Inc. Processes and intermediates for preparing 3-amino-benzo(b)azepinones
ES2171196T3 (es) * 1994-10-14 2002-09-01 Glaxosmithkline Spa Uso de antagonistas del receptor cck-b para el tratamiento de trastornos del sueño.
DE10153348A1 (de) * 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte Benzo(b)azepin-2-on-Verbindungen
WO2007120160A2 (en) * 2005-06-16 2007-10-25 Novartis Ag Lactam containing hcv inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
US4767756A (en) * 1987-07-17 1988-08-30 E. R. Squibb & Sons, Inc. 3-substituted benzazepines
EP0322779A3 (en) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolactam compounds and pharmaceutical uses thereof
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck

Also Published As

Publication number Publication date
CN1074903A (zh) 1993-08-04
WO1993015059A1 (en) 1993-08-05
JPH07503465A (ja) 1995-04-13
CZ391092A3 (en) 1994-01-19
EP0625145A1 (en) 1994-11-23
TW213901B (sr) 1993-10-01
CA2117367A1 (en) 1993-08-05
YU4393A (sr) 1996-01-09
NO942775D0 (no) 1994-07-26
KR950700257A (ko) 1995-01-16
IL104472A0 (en) 1993-05-13
RU94038063A (ru) 1996-05-27
FI943513A7 (fi) 1994-07-26
AU3276193A (en) 1993-09-01
FI943513L (fi) 1994-07-26
HUT70496A (en) 1995-10-30
FI943513A0 (fi) 1994-07-26
ZA93582B (en) 1994-07-27
HU9402195D0 (en) 1994-09-28
BR9207071A (pt) 1995-12-05
NO942775L (no) 1994-09-20
MX9300409A (es) 1993-07-01

Similar Documents

Publication Publication Date Title
AU2006298995B2 (en) Pyrazolo [1, 5 -alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists
CA2402751C (en) Decahydro-isoquinolines
AU2015320859A1 (en) Novel compounds
CN104334554B (zh) 作为bace1抑制剂的5‑氨基[1,4]噻嗪类
DK151800B (da) Analogifremgangsmaade til fremstilling af et 2-phenylenmorpholinderivat, herunder dettes optiske isomere, eller et farmaceutisk acceptabelt syreadditionssalt deraf
DE69419157T2 (de) Tetrahydro-1h-benzazepinone und hexahydro azepinone als selektive cholecystokinin-b rezeptor antagonisten
PL193041B1 (pl) Nowe pochodne indolo-2, 3-diono-3-oksymu, kompozycja farmaceutyczna zawierająca te związki oraz ich zastosowanie
US5484917A (en) Substituted tetrahydrobenzazepinones
NZ245759A (en) Substituted hexahydroazepinones and tetrahydrobenzazepinones, preparation, intermediates and pharmaceutical compositions thereof
US5556909A (en) Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof
KR20090041387A (ko) 마크로시클릭 락탐
EP1802628A1 (en) Crystalline forms and process for preparing spiro-hydantoin compounds
JP4109709B1 (ja) 統合失調症の治療のためのテトラヒドロ−ピリドアゼピン−8−オン及び関連化合物
CA2655399A1 (en) Pyrrolidine derivatives having activity at the glyt1 transporter
JPH04108789A (ja) イミダゾベンゾジアゼピン類及びそれらの塩の新規の製造方法、新規のイミダゾベンゾジアゼピン類及びそれらの塩並びにそれらの薬剤としての使用
US5602154A (en) 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
JP3323462B2 (ja) +)−シス−(3R)−アミノ−8−メチル−(5R)−フェニル−1,3,4,5−テトラヒドロ−ベンゾ[b]アゼピン−2−オンを製造するための中間体の製造方法
WO1984002704A2 (en) Tetracyclic compounds
CA2297612C (en) Processes and intermediates for preparing 3-amino-benzo(b)azepinones
KR840000035B1 (ko) 벤즈아제핀 유도체의 제조방법
JPS608294A (ja) 6−(アミノメチル)ペニシラン酸1,1−ジオキシドエステルおよびその中間体
JPH08506572A (ja) ピラゾール誘導体およびその医薬組成物